816 related articles for article (PubMed ID: 18571008)
1. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
2. CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility.
Srivastava A; Pandey SN; Choudhuri G; Mittal B
Scand J Immunol; 2008 May; 67(5):516-22. PubMed ID: 18405329
[TBL] [Abstract][Full Text] [Related]
3. IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population.
Vishnoi M; Pandey SN; Choudhuri G; Mittal B
Cancer Genet Cytogenet; 2008 Oct; 186(2):63-8. PubMed ID: 18940468
[TBL] [Abstract][Full Text] [Related]
4. Complement receptor 1 (A3650G RsaI and intron 27 HindIII) polymorphisms and risk of gallbladder cancer in north Indian population.
Srivastava A; Mittal B
Scand J Immunol; 2009 Dec; 70(6):614-20. PubMed ID: 19906204
[TBL] [Abstract][Full Text] [Related]
5. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population.
Srivastava A; Srivastava K; Pandey SN; Choudhuri G; Mittal B
Ann Surg Oncol; 2009 Jun; 16(6):1695-703. PubMed ID: 19266243
[TBL] [Abstract][Full Text] [Related]
6. Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a north Indian population.
Pandey SN; Choudhuri G; Mittal B
Eur J Cancer Prev; 2008 Apr; 17(2):77-81. PubMed ID: 18287863
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancer.
Srivastava A; Pandey SN; Dixit M; Choudhuri G; Mittal B
J Gastroenterol Hepatol; 2008 Jun; 23(6):970-5. PubMed ID: 17944886
[TBL] [Abstract][Full Text] [Related]
8. The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.
Eliopoulos DG; Mavroudi I; Pontikoglou C; Ximeri M; Stavroulaki E; Pyrovolaki K; Velegraki M; Spanoudakis M; Goulielmos G; Papadaki HA
Eur J Haematol; 2009 Dec; 83(6):535-40. PubMed ID: 19614955
[TBL] [Abstract][Full Text] [Related]
9. Significant association between toll-like receptor gene polymorphisms and gallbladder cancer.
Srivastava K; Srivastava A; Kumar A; Mittal B
Liver Int; 2010 Aug; 30(7):1067-72. PubMed ID: 20492496
[TBL] [Abstract][Full Text] [Related]
10. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma.
Wei YS; Zhu YH; Du B; Yang ZH; Liang WB; Lv ML; Kuang XH; Tai SH; Zhao Y; Zhang L
Clin Chim Acta; 2007 May; 380(1-2):165-9. PubMed ID: 17368597
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer.
Amirghofran Z; Jalali SA; Ghaderi A; Hosseini SV
Cancer Genet Cytogenet; 2009 Apr; 190(1):21-5. PubMed ID: 19264229
[TBL] [Abstract][Full Text] [Related]
12. The relationship between the TGF-beta1 gene -509C/T polymorphism and tubulointerstitial damage resulting from primary nephrotic syndrome.
Li Y; Liu FY; Peng YM; Li J; Sun L; Chen X; Duan SB; Ling GH; Guo N; Liu YH
Ren Fail; 2010 May; 32(4):420-7. PubMed ID: 20446778
[TBL] [Abstract][Full Text] [Related]
13. Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease.
Koch W; Hoppmann P; Mueller JC; Schömig A; Kastrati A
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1114-9. PubMed ID: 16543493
[TBL] [Abstract][Full Text] [Related]
14. Analysis of common transforming growth factor beta-1 gene polymorphisms in gastric and duodenal ulcer disease: pilot study.
Polonikov AV; Ivanov VP; Belugin DA; Khoroshaya IV; Kolchanova IO; Solodilova MA; Tutochkina MP; Stepchenko AA
J Gastroenterol Hepatol; 2007 Apr; 22(4):555-64. PubMed ID: 17376051
[TBL] [Abstract][Full Text] [Related]
15. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer.
Kang HG; Choi JE; Lee WK; Kam S; Cha SI; Kim CH; Jung TH; Park JY
Respirology; 2007 Nov; 12(6):902-5. PubMed ID: 17986122
[TBL] [Abstract][Full Text] [Related]
16. Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility.
Teixeira AL; Ribeiro R; Morais A; Lobo F; Fraga A; Pina F; Calais-da-Silva FM; Calais-da-Silva FE; Medeiros R
Pharmacogenomics J; 2009 Oct; 9(5):341-6. PubMed ID: 19488063
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease.
Araújo AP; Ribeiro R; Pinto D; Pereira D; Sousa B; Mauricio J; Lopes C; Medeiros R
DNA Cell Biol; 2009 May; 28(5):265-9. PubMed ID: 19388850
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma.
Wei YS; Xu QQ; Wang CF; Pan Y; Liang F; Long XK
Tissue Antigens; 2007 Dec; 70(6):464-9. PubMed ID: 17990985
[TBL] [Abstract][Full Text] [Related]
20. Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor beta1 gene.
Chang SJ; Chen CJ; Tsai FC; Lai HM; Tsai PC; Tsai MH; Ko YC
Rheumatology (Oxford); 2008 May; 47(5):617-21. PubMed ID: 18356176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]